Vinge advises Randviken Fastigheter AB (publ) (”Randviken”) in connection with its change of company…
Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova w…
Vinge has advised Azelio in connection with a directed share issue whereby Azelio raises approximate…
Vinge is advising Medivir AB (publ) in connection with a rights issue which will provide Medivir wit…
Vinge advises the Swedish state in connection with the recapitalization of SAS. The recapitalization…
Altor Fund V and Stena Adactum AB have, through the jointly controlled company GB HoldCo AB, announc…
Vinge has advised Azelio, a public Swedish company specialising in thermal energy storage with dispa…
Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm…
The board of directors of Samhällsbyggnadsbolaget i Norden has, on the basis of an authorization gra…
Vinge advises Calliditas Therapeutics in connection with its capital raising and listing on The Nasd…
Vinge has advised Nanoform Finland Plc (“Nanoform”) in connection with its capital raising and listi…
Vinge has advised Azelio AB (publ) on a fully subscribed rights issue, which will provide Azelio wit…
Vinge has advised the global investment firm KKR in connection with KKR entering into an agreement w…
Vinge has advised Strax AB in connection with an automatic redemption procedure according to which e…
The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, wh…
